Your browser doesn't support javascript.
loading
Phase II Study of a Non-Platinum-Containing Doublet of Paclitaxel and Pemetrexed with Bevacizumab as Initial Therapy for Patients with Advanced Lung Adenocarcinomas.
Pietanza, M C; Hellmann, Matthew D; Fiore, John J; Smith-Marrone, Stephanie; Basch, Ethan M; Schwartz, Lawrence H; Ginsberg, Michelle S; Shouery, Marwan; Newman, Samantha K; Shaw, Mary; Rogak, Lauren J; Lash, Alex E; Hilden, Patrick; Kris, Mark G.
Afiliación
  • Pietanza MC; Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York.
  • Hellmann MD; Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York.
  • Fiore JJ; Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Smith-Marrone S; Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Basch EM; University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina.
  • Schwartz LH; Department of Radiology, Columbia University Medical Center, New York Presbyterian Hospital, New York, New York.
  • Ginsberg MS; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Radiology, Weill Cornell Medical College, New York, New York.
  • Shouery M; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Newman SK; Department of Medicine, NYU School of Medicine, New York, New York.
  • Shaw M; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Rogak LJ; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Lash AE; Simons Foundation, New York, New York.
  • Hilden P; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Kris MG; Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York. Electronic address: krism@mskcc.org.
J Thorac Oncol ; 11(6): 890-9, 2016 06.
Article en En | MEDLINE | ID: mdl-26964771
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias Pulmonares Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Thorac Oncol Año: 2016 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias Pulmonares Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Thorac Oncol Año: 2016 Tipo del documento: Article